01/15/2025 7:00 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 4:34 PM | Biogen (Filed by) Sage Therapeutics, Inc. (Subject)
| Form SCHEDULE 13D | |
01/07/2025 3:14 PM | Biogen (Issuer) Pangalos Menelas N (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/09/2024 3:56 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 3:57 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 9:33 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 3:23 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/04/2024 10:20 AM | Biogen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/30/2024 3:45 PM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 3:31 PM | Biogen (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024 5:55 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/16/2024 11:11 AM | Biogen (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
10/07/2024 6:08 PM | Biogen (Issuer) Minor Lloyd (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/12/2024 6:31 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 5:00 AM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 12:00 PM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024 5:40 PM | Biogen (Filed by) SANGAMO THERAPEUTICS, INC (Subject)
| Form SC 13G/A | |
08/01/2024 5:55 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:01 PM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:06 PM | Biogen (Issuer) DORSA CAROLINE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:13 PM | Biogen (Issuer) Freire Maria C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:14 PM | Biogen (Issuer) HAWKINS WILLIAM A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:15 PM | Biogen (Issuer) Patolawala Monish D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:16 PM | Biogen (Issuer) LANGER SUSAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:18 PM | Biogen (Issuer) Rowinsky Eric K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:19 PM | Biogen (Issuer) Mantas Jesus B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:20 PM | Biogen (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:08 PM | Biogen (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 7:00 PM | Biogen (Issuer) Keeney Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:15 PM | Biogen (Filer)
| Form ARS | |
04/24/2024 3:15 PM | Biogen (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 6:02 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 4:01 PM | Biogen (Filer)
| Form PRE 14A | |
04/03/2024 7:24 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:11 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 9:08 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 6:54 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 9:12 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:31 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:33 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:36 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The #1 Stock for Trump’s Second Term? (Ad) Imagine how much money you could make if you bought all of the top performing stocks during Trump's second term?
Well, legendary investor Louis Navellier's stock rating system...
Gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term... Click here now because these stocks could turn out to be the top performers of Trump's second term. |
02/21/2024 8:39 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:27 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:28 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:29 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 9:24 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 8:13 PM | Biogen (Issuer) Rowinsky Eric K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:56 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:00 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:01 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:03 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:04 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:06 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:14 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 6:07 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:07 PM | Biogen (Filed by) Denali Therapeutics Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 6:11 PM | Biogen (Filed by) SANGAMO THERAPEUTICS, INC (Subject)
| Form SC 13G/A | |
02/12/2024 10:21 AM | Biogen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/12/2024 10:10 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 9:50 AM | Biogen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:11 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:12 PM | Biogen (Issuer) Grogan Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:14 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:16 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 6:56 PM | Biogen (Issuer) Viehbacher Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 6:59 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:01 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:03 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:06 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:08 PM | Biogen (Issuer) Keeney Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:38 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 9:44 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 4:34 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:35 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:36 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:27 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:30 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:31 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:33 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |